Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

QR Code

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...

Full description

Bibliographic Details
Main Authors:	Bimbo Diaz, Alejandro, Chow, Jeremy, Fan, Kee Hoo, Kok, Wei Koh, Chin, Gary Keong Lee, Wee, Siong Teo, Venketasubramanian, Narayanaswamy, Chun, Chieh Wang, Mehta, Radhika
Format:	Article
Language:	English
Published:	Bioexcel Publishing 2023
Online Access:	http://psasir.upm.edu.my/id/eprint/107426/ http://psasir.upm.edu.my/id/eprint/107426/1/107426.pdf

Similar Items

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation
by: Koya Kutty, Shahedah, et al.
Published: (2018)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)

Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care
by: Taggar, Jaspal, et al.
Published: (2016)

Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)

Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis
by: Mohd, Noor Norhayati, et al.
Published: (2020)

Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis
by: Taggar, Jaspal S., et al.
Published: (2015)

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Filion, K., et al.
Published: (2011)

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study
by: Filion, K., et al.
Published: (2015)

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study
by: Lopez, F., et al.
Published: (2012)

Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)
by: Lopez, F., et al.
Published: (2013)

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
by: Huxley, Rachel, et al.
Published: (2011)

Birth weight and the risk of atrial fibrillation in whites and African Americans: The atherosclerosis risk in communities (ARIC) study
by: Lawani, S., et al.
Published: (2014)

Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: a systematic review and meta-analysis
by: Taggar, Jaspal S., et al.
Published: (2015)

Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?
by: Alamneh, E., et al.
Published: (2016)